25 min listen
Capstan Therapeutics' CEO Laura Shawver on In Vivo Cell Engineering
Capstan Therapeutics' CEO Laura Shawver on In Vivo Cell Engineering
ratings:
Length:
40 minutes
Released:
Nov 10, 2022
Format:
Podcast episode
Description
Capstan Therapeutics' CEO, Laura Shawver, Ph.D., talks us through the company's in vivo CAR therapies and what led to the in vivo cell engineering breakthrough that has been decades in the making. Shawver explains the promise of harnessing mRNA and targeted LNP delivery to train a patient’s body to make CAR-T cells in vivo. She also details best practices to garner funding and investment partnership.
Released:
Nov 10, 2022
Format:
Podcast episode
Titles in the series (76)
Advancing Patient Engagement with Novartis Gene Therapies' Dr. Amy Nicole Nayar by Cell & Gene: The Podcast